News tagged with cancer clinical trials
Glowing Cornell dots -- a potential cancer diagnostic tool set for human trials
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
Nanotechnology / Bio & Medicine
Jun 13, 2011 |
5 / 5 (5) |
1
|
RxPONDER trial will evaluate whether gene expression test can drive chemotherapy choice
Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.
Apr 26, 2011 |
not rated yet |
0
Vitamin A derivative can inhibit early forms of breast cancer
A nutrient found in carrots and sweet potatoes may prove key to fighting breast cancer at early stages, according to a new study by researchers at Fox Chase Cancer Center. Sandra Fernandez, PhD, an assistant research professor ...
Apr 05, 2011 |
not rated yet |
0
New target identified for squamous cell lung cancer
Scientists at the Dana Farber Cancer Institute have identified a mutation in the DDR2 gene that may indicate which patients with squamous cell lung cancer will respond to dasatinib.
Apr 03, 2011 |
not rated yet |
0
Study puts notch on the jagged edge of lung cancer metastasis
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical In ...
Mar 14, 2011 |
5 / 5 (1) |
0
Targeted ovarian cancer therapy not cost-effective: study
An analysis conducted by Ohio State University cancer researchers has found that adding the targeted therapy bevacizumab to the treatment of patients with advanced ovarian cancer is not cost effective.
Mar 07, 2011 |
not rated yet |
0
UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure ...
Feb 15, 2011 |
not rated yet |
0
Few physicians refer patients to cancer clinical trials
A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute.
Feb 12, 2011 |
5 / 5 (1) |
0
Areva to begin US trial of cancer-fighting isotope
A subsidiary of the French nuclear giant Areva said Monday it had received US clearance to begin a clinical trial of an isotope that targets cancer cells.
Jan 24, 2011 |
4 / 5 (3) |
1
New drug uses stealth to stop cancer cell reproduction
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper ...
Jan 12, 2011 |
not rated yet |
0
Quality of life measures in breast cancer clinical trials
Quality of life measures tend to be most useful for clinical decision-making in trials in which quality of life is the primary outcome, according to a recent study published online January 7 in The Journal of the National Ca ...
Jan 07, 2011 |
not rated yet |
0
UF hepatologists test chemotherapy pill in patients with advanced liver cancer, cirrhosis
Hepatologists at the University of Florida have begun a new clinical trial in search of a better way to treat patients who have advanced, inoperable primary liver cancer but have trouble tolerating standard doses of the only ...
Dec 21, 2010 |
5 / 5 (2) |
0
Personalized molecular therapy shows promising results for people with advanced lung cancer
A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced lung cancer according to research presented at the 2010 Chicago Multidisciplinary Symposium ...
Dec 09, 2010 |
not rated yet |
0
Phase I trial indicates ponatinib may thwart most resistant CML
A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from ...
Dec 06, 2010 |
not rated yet |
0
Celecoxib may be effective in preventing non-melanoma skin cancers
Celecoxib may help prevent nonmelanoma skin cancers in patients with extensive actinic keratosis, which is often a precursor to these cancers, according to a randomized clinical trial published online November 29 in The Jo ...
Nov 29, 2010 |
not rated yet |
0
